Detalhe da pesquisa
1.
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors.
Circulation
; 147(13): 1026-1038, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802876
2.
Prospective Observational Cohort Study of Tenecteplase Versus Alteplase in Routine Clinical Practice.
Stroke
; 53(12): 3583-3593, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36148657
3.
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.
N Engl J Med
; 380(14): 1326-1335, 2019 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30730782
4.
Use of deep artificial neural networks to identify stroke during triage via subtle changes in circulating cell counts.
BMC Neurol
; 22(1): 206, 2022 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659609
5.
Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.
Stroke
; 52(6): 2096-2105, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33966491
6.
Anticoagulant Reversal in Gastrointestinal Bleeding: Review of Treatment Guidelines.
Dig Dis Sci
; 66(11): 3698-3714, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403486
7.
Tenecteplase Thrombolysis for Acute Ischemic Stroke.
Stroke
; 51(11): 3440-3451, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33045929
8.
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
Stroke
; 51(6): 1758-1765, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32404035
9.
Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel.
Ann Emerg Med
; 76(4): 470-485, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732375
10.
A review of guidelines on anticoagulation reversal across different clinical scenarios - Is there a general consensus?
Am J Emerg Med
; 38(9): 1890-1903, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32750627
11.
Intravenous Thrombolysis at 3.5 Hours From Onset of Pediatric Acute Ischemic Stroke.
Pediatr Emerg Care
; 36(1): e4-e7, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29406476
12.
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.
N Engl J Med
; 375(12): 1131-41, 2016 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27573206
13.
Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non-vitamin K Anticoagulant Reversal.
Anesthesiology
; 129(6): 1171-1184, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30157037
14.
Antifibrinolytic Therapy and Perioperative Considerations.
Anesthesiology
; 128(3): 657-670, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29200009
15.
Management of Factor Xa inhibitor-associated life-threatening major hemorrhage: A retrospective multi-center analysis.
Am J Emerg Med
; 36(3): 396-402, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843518
16.
Andexanet Alfa for Bleeding with Factor Xa Inhibitors. Reply.
N Engl J Med
; 381(2): 192-193, 2019 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31291534
17.
Celebrating Annals of Emergency Medicine's 50th Anniversary.
Ann Emerg Med
; 79(1): 1, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34949404
18.
Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review.
Ann Emerg Med
; 69(5): 531-540, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28196608
19.
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial.
Lancet
; 385(9982): 2077-87, 2015 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25728933
20.
Thromboembolic Events After Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate: Exploratory Analyses of Two Randomized, Plasma-Controlled Studies.
Ann Emerg Med
; 67(1): 96-105.e5, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26094105